Consumer health in 2025: The big picture
Toward the end of the review period, sales of consumer health products in Côte d’Ivoire remained moderate, reflecting a relatively stable performance despite a challenging economic environment. Pharmaceutical imports declined by 10% between 2023 and 2024, signalling a slowdown in the sector and highlighting the country’s dependence on external supply. At the same time, the Ivorian government reduced its health budget by 10%, a decision that had a direct impact on the supply chain and limited investment in healthcare infrastructure. Local pharmaceutical production also fell by 4%, pointing to persistent difficulties within the national industry. Adding to these pressures, pharmaceutical product prices increased by an average of 5% in 2024, which restricted access to medicines for vulnerable populations. Many of these groups remain sensitive to price fluctuations and continue to rely on traditional medicines when modern treatments become less affordable.
Key trends in 2025
The consumer health sector in Côte d’Ivoire remains heavily dependent on imports, which account for close to 90% of the pharmaceutical products available. To address this dependency, both public and private stakeholders are directing investment towards strengthening local production, with short-term targets aiming for 20% of medicines to be manufactured domestically. In 2023, an estimated €54 million was invested in the construction of pharmaceutical manufacturing plants and a national storage centre, illustrating the government’s determination to reduce reliance on imports. In parallel, the Universal Health Coverage system (CMU), Côte d’Ivoire’s national health insurance scheme, now provides more than 13 million subscribers with access to essential medications as of 2025, significantly improving healthcare accessibility. However, the informal market continues to pose a major challenge, with around one-third of medicines still sold outside regulated channels. This raises concerns about product quality, safety, and traceability for consumers, and remains a central issue for policymakers.
Competitive landscape
Sanofi currently stands as the leading pharmaceutical player in Côte d’Ivoire, with a strong presence across pharmacies nationwide. Its flagship product Doliprane is widely cited by Ivorian consumers for its effectiveness and affordability, and it remains available even in open markets, reinforcing the brand’s visibility and reach. Sanofi has more than 117 medicines listed in the pharmacists’ union database, covering a wide range of health conditions. The breadth of its portfolio, coupled with broad pharmacy availability, consolidates the company’s dominant position in the country.
Channel developments
Pharmacies remain the primary point of sale for over-the-counter medicines in Côte d’Ivoire, as the government continues to emphasise strict product traceability and consumer safety. By concentrating distribution through licensed pharmacies, authorities aim to reduce the circulation of counterfeit or poor-quality medicines, which remain a major public health concern in the country. For other product types, such as vitamins and dietary supplements, specialised retail outlets are also present, providing consumers with additional purchasing options and sometimes offering a broader assortment of imported brands. In parallel, supermarkets and convenience stores are gradually expanding their health product ranges, particularly in urban centres, reflecting rising consumer interest in wellness solutions. E-commerce platforms are also gaining visibility, especially among younger, digitally connected populations in Abidjan and other large cities, offering convenience and discreet access to health products. While pharmacies remain dominant, these evolving channels highlight the gradual diversification of access points for consumer health products across the country.
What next for consumer health?
Over the forecast period, consumer health in Côte d’Ivoire is expected to see notable growth, supported by public and private initiatives promoting local pharmaceutical production. Authorities have set clear objectives, targeting 20% local output by 2025 and 30% by 2030, in order to reduce reliance on imports. Reflecting this ambition, the national health budget for 2025 has been raised by more than 20%, signalling a strong governmental commitment to expanding healthcare access and supporting the sector. Significant investment is also underway, with USD16 million mobilised at the end of 2023 to strengthen pharmaceutical production capacity. This funding is intended to modernise existing facilities, increase domestic output, and gradually reduce dependence on external suppliers.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Consumer Health industry in Côte d'Ivoire with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
Data and analysis in this report provides further detailed coverage dedicated to the following key categories, where applicable:
- Analgesics
- Cough, Cold and Allergy Remedies
- Digestive Remedies
- Dermatologicals
- NRT Smoking Cessation Aids
- Sleep Aids
- Eye Care
- Wound Care
- Vitamins
- Dietary Supplements
- Weight Management
- Sports Nutrition
- Herbal/Traditional Products
- Paediatric Consumer Health
If you're in the Consumer Health industry in Côte d'Ivoire, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Consumer Health in Côte d'Ivoire report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Consumer Health in Côte d'Ivoire?
- Which are the leading brands in Consumer Health in Côte d'Ivoire?
- How are products distributed in Consumer Health in Côte d'Ivoire?
- How has the regulatory and operating environment for Consumer Health changed in Côte d'Ivoire?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Consumer Health
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Consumer Health in Côte d'Ivoire
Consumer health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
DISCLAIMER
Key Data Findings
2025 Developments
Rising self-medication drives demand for analgesics
Established brands remain the most trusted choice for consumers
Digital platforms and regulatory action reshape access to medicines
Prospects and Opportunities
Self-medication expected to remain a key growth driver
Expansion of mobile applications enhances consumer access
Investments in local production promise greater resilience
Category Data
Key Data Findings
2025 Developments
Rising respiratory infections fuel higher demand for treatments
Rhinathiol remains the leading brand thanks to insurance coverage
Pharmacy exclusivity reinforces official distribution channels
Prospects and Opportunities
Rainy season expected to sustain cyclical demand
Strengthened traceability combats counterfeit medicines
Growing awareness of allergy management creates new opportunities
Category Data
Key Data Findings
2025 Developments
Parents increasingly use digestive remedies to manage diarrhoeal disease in children
Sanofi and Smecta dominate with trusted brands and flexible formats
Growing role of regulatory scrutiny and conventional channels in ensuring safety
Prospects and Opportunities
Traditional medicine adaptation could widen reach and acceptance
Price sensitivity and rural infrastructure improvements promise greater access
Increasing burden of diarrhoeal disease may drive demand and innovation
Category Data
Key Data Findings
2025 Developments
Fragmentation defines the competitive environment
Misuse of Betadine raises regulatory and health concerns
Growing consumer interest supports diverse product uptake
Digital platforms expand access to dermatologicals
Antifungal and topical treatments remain a key growth area
Rising awareness of skin health fuels preventive care
Category Data
Key Data Findings
2025 Developments
Self-medication remains widespread for wound treatment
Established brands reinforce long-standing consumer habits
Pharmacies remain central, with growing availability in general retail
Prospects and Opportunities
Maturity of the sector limits future growth potential
Innovation in materials and formats offers scope for differentiation
Expansion of modern retail and e-commerce enhances accessibility
Category Data
Key Data Findings
2025 Developments
Vitamin C drives rising demand among students and professionals
Sanofi consolidates leadership with CAC 1000
Pharmacies remain the primary distribution channel
Lifestyle changes and rising purchasing power boost demand
Paediatric supplementation strengthened by humanitarian initiatives
Traditional and herbal supplements gain recognition
Category Data
2025 Developments
Herbal teas and natural products underpin demand
Limited penetration of specialised products constrains growth
Awareness of lifestyle diseases slowly influences behaviour
Prospects and Opportunities
Traditional remedies expected to remain central
Rising health consciousness could expand demand
Digital platforms create new channels for wellbeing products
Category Data
2025 Developments
Emerging gym culture fuels niche demand
Protein powders and energy products gain visibility
Distribution limited to specialised channels
Prospects and Opportunities
Rising interest in fitness supports long-term potential
Local innovation could expand affordability and access
Digital platforms broaden reach for niche products
Category Data
Key Data Findings
2025 Developments
Pharmacists call for a stronger role in herbal medicine
Local companies such as Phytoravie consolidate their position
Research and education expand consumer awareness
Prospects and Opportunities
Regulatory framework strengthens quality and export potential
Industrial-scale development of antimalarial phytomedicines
Domestication of “savannah tea” supports sustainable cultivation
Category Data
The following categories and subcategories are included:
Consumer Health
-
- Adult Mouth Care
-
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
-
- Sleep Aids
-
- Antihistamines/Allergy Remedies (Systemic)
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
- Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
- Cough Remedies
-
- Nasal Sprays
- Oral Decongestants
- Inhalant Decongestants
- Decongestant Rubs
- Nasal Decongestant Drops
- Nasal Decongestant Plasters
- Medicated Confectionery
- Pharyngeal Preparations
-
- Medicated Shampoos
- Topical Antifungals
- Vaginal Antifungals
- Hair Loss Treatments
- Nappy (Diaper) Rash Treatments
- Antiparasitics/Lice (Head and Body) Treatments
- Antipruritics
- Cold Sore Treatments
- Haemorrhoid Treatments
- Paediatric Dermatologicals
- Topical Allergy Remedies/Antihistamines
- Topical Germicidals/Antiseptics
-
-
- Paediatric Diarrhoeal Remedies
- Paediatric Indigestion and Heartburn Remedies
- Paediatric Laxatives
- Paediatric Motion Sickness Remedies
- Diarrhoeal Remedies
- IBS Treatments
-
- Antacids
- Antiflatulents
- Digestive Enzymes
- H2 Blockers
- Proton Pump Inhibitors
- Laxatives
- Motion Sickness Remedies
-
- Emergency Contraception
-
- Allergy Eye Care
- Standard Eye Care
-
- NRT Gum
- NRT Inhalators
- NRT Lozenges
- NRT Patches
- Other NRT
-
- First Aid Kits
- Gauze, Tape and Other Wound Care
- Sticking Plasters/Adhesive Bandages
-
-
- Protein/Energy Bars
- Sports Protein Powder
- Sports Protein RTD
- Sports Non-Protein Products
-
-
-
- Combination Dietary Supplements
-
- Aloe
- Combination Herbal/Traditional Dietary Supplements
- Cranberry
- Echinacea
- Evening Primrose Oil
- Garlic
- Ginkgo Biloba
- Ginseng
- St John's Wort
- Other Herbal/Traditional Dietary Supplements
-
- Co-Enzyme Q10
- Combination Non-Herbal/Traditional Dietary Supplements
- Eye Health Supplements
- Fish Oils/Omega Fatty Acids
- Glucosamine
-
- Calcium Supplements
- Mineral Supplements
- Probiotic Supplements
- Protein Supplements
- Other Non-Herbal/Traditional Dietary Supplements
- Paediatric Vitamins and Dietary Supplements
- Tonics
-
- Multivitamins
-
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Vitamin E
- Other Single Vitamins
-
-
- Meal Replacement
- OTC Obesity
- Slimming Teas
- Supplement Nutrition Drinks
- Weight Loss Supplements
-
- Herbal/Traditional Topical Analgesics
- Herbal/Traditional Sleep Aids
- Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
- Herbal/Traditional Digestive Remedies
- Herbal/Traditional Dermatologicals
- Herbal/Traditional Paediatric Dietary Supplements
- Herbal/Traditional Dietary Supplements
- Herbal/Traditional Tonics
-
- Allergy Eye Care
- Antihistamines/Allergy Remedies (Systemic)
- Paediatric Allergy Remedies
- Topical Allergy Remedies/Antihistamines
-
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
-
- Paediatric Diarrhoeal Remedies
- Paediatric Indigestion and Heartburn Remedies
- Paediatric Laxatives
- Paediatric Motion Sickness Remedies
- Paediatric Dermatologicals
- Nappy (Diaper) Rash Treatments
- Paediatric Vitamins and Dietary Supplements
-
Consumer Health
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Consumer Health research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!